Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$7.3B |
| 2 |
Eli Lilly
LLY
|
+$3.9B |
| 3 |
Starbucks
SBUX
|
+$3.78B |
| 4 |
Arista Networks
ANET
|
+$1.4B |
| 5 |
Dominion Energy
D
|
+$1.23B |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$4.7B |
| 2 |
Gilead Sciences
GILD
|
+$2.61B |
| 3 |
Salesforce
CRM
|
+$2.56B |
| 4 |
GE HealthCare
GEHC
|
+$2.31B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.77B |
Sector Composition
| 1 | Technology | 29.16% |
| 2 | Consumer Discretionary | 13.59% |
| 3 | Healthcare | 12.72% |
| 4 | Industrials | 11.43% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Haemonetics
HAE
$2.46B
| $85M | 0.02% |
1,139,043
-438,280
| -28% | -$32.7M |
|
302
Patrick Industries
PATK
$3.59B
| $84.4M | 0.02% |
914,516
-700,950
| -43% | -$64.7M |
|
303
Alaska Air
ALK
$6.66B
| $84.1M | 0.02% |
1,700,000
| – | – |
|
304
First Advantage
FA
$2.72B
| $83.8M | 0.02% |
5,044,562
-986,238
| -16% | -$16.4M |
|
305
Matsons
MATX
$3.34B
| $82.3M | 0.02% |
738,891
+11,683
| +2% | +$1.3M |
|
306
SS&C Technologies
SSNC
$21.6B
| $79.8M | 0.02% |
963,763
-99,987
| -9% | -$8.28M |
|
307
nCino
NCNO
$3.5B
| $79.1M | 0.02% |
2,826,919
| – | – |
|
308
Encompass Health
EHC
$12.5B
| $79M | 0.02% |
644,233
| – | – |
|
309
Boot Barn
BOOT
$5.44B
| $78.7M | 0.02% |
518,007
+55,389
| +12% | +$8.42M |
|
310
Vale
VALE
$46.4B
| $78.6M | 0.02% |
8,099,417
+17,199
| +0.2% | +$167K |
|
311
Applied Industrial Technologies
AIT
$9.82B
| $78M | 0.02% |
335,622
+1,523
| +0.5% | +$354K |
|
312
Lamb Weston
LW
$8.03B
| $76.2M | 0.02% |
1,470,000
+124,749
| +9% | +$6.47M |
|
313
Southern Company
SO
$101B
| $75.7M | 0.02% |
824,394
+281
| +0% | +$25.8K |
|
314
Essent Group
ESNT
$6.18B
| $74.3M | 0.01% |
1,224,193
+5,821
| +0.5% | +$354K |
|
315
Lowe's Companies
LOW
$152B
| $73.1M | 0.01% |
329,672
+39,752
| +14% | +$8.82M |
|
316
State Street
STT
$31.5B
| $72.5M | 0.01% |
681,940
-78,060
| -10% | -$8.3M |
|
317
Deere & Co
DE
$127B
| $71.4M | 0.01% |
140,335
+957
| +0.7% | +$487K |
|
318
Elastic
ESTC
$9.21B
| $69.9M | 0.01% |
828,543
+4,318
| +0.5% | +$364K |
|
319
First American
FAF
$6.75B
| $68.9M | 0.01% |
+1,122,623
| New | +$68.9M |
|
320
GSK
GSK
$81B
| $68.2M | 0.01% |
1,776,812
+14,654
| +0.8% | +$563K |
|
321
Denali Therapeutics
DNLI
$1.95B
| $66.5M | 0.01% |
4,750,579
-14,558
| -0.3% | -$204K |
|
322
Nutrien
NTR
$27.5B
| $66M | 0.01% |
1,133,777
+7,549
| +0.7% | +$440K |
|
323
Western Union
WU
$2.63B
| $64.7M | 0.01% |
7,679,907
+9,331
| +0.1% | +$78.6K |
|
324
Tetra Tech
TTEK
$9.53B
| $64.3M | 0.01% |
+1,787,103
| New | +$64.3M |
|
325
Fiserv
FI
$72.4B
| $63.6M | 0.01% |
369,148
+2,518
| +0.7% | +$434K |
|